About OraVerse
OraVerse was founded in 2007 and is based in Lancaster, United States. The company operates in the dental healthcare sector, focusing on a website that delivers details about OraVerse, a specialized dental injection used for anesthesia reversal. Services include educational resources on product usage, benefits, and clinical applications, targeted at dental professionals and patients across the United States.
- Headquarter Lancaster, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OraVerse
Detailed funding history for OraVerse
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in OraVerse
OraVerse has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Septodont.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A portfolio of dental products across multiple categories is developed.
|
Locked | Locked | Locked |
Investor details for OraVerse
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OraVerse
Investment portfolio details for OraVerse
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OraVerse
Detailed financials for OraVerse
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oraverse Comparisons
Peer comparison for OraVerse
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OraVerse
Detailed competitors of OraVerse
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oraverse
Complete news archive for OraVerse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OraVerse
OraVerse was founded in 2007.
OraVerse is headquartered in Lancaster, United States. It is registered at Lancaster, Pennsylvania, United States.
OraVerse was founded in 2007 and is based in Lancaster, United States. The company operates in the dental healthcare sector, focusing on a website that delivers details about OraVerse, a specialized dental injection used for anesthesia reversal. Services include educational resources on product usage, benefits, and clinical applications, targeted at dental professionals and patients across the United States.
OraVerse has 1 investor. Key investors include Septodont.